Cure Alzheimer's Fund
OTHER
INVESTOR TYPE
3
INVESTMENTS
1
PORTFOLIO
1
EXITS
Primary Investor Type
Angel (individual)
Cure Alzheimer's Fund Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Amylyx | 22-Aug-2016 | Early Stage VC | 000 | Biotechnology | Generating Revenue | |
| 000000 | 20-Jul-2016 | 00000 | 00.000 | Biotechnology | Generating Revenue | |
| 00000 000000000000 | 16-Jul-2013 | 00000 | Drug Discovery | Clinical Trials - Phase 2 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Cure Alzheimer's Fund’s full profile, request a free trial.
Cure Alzheimer's Fund Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000 000000000000 | 29-May-2019 | 000000000000000000 | 00000 | Completed |
|
Cure Alzheimer's Fund Co-Investors (4)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| ALS Finding a Cure Foundation | 1 | ||
| ALS Investment Fund | 0 | 0 | |
| Henri Termeer | 0 | 0 | |
| Morningside Group | 0 | 0 |